Large-scale testing (Phase 3)Active Not RecruitingNCT02511106
What this trial is testing
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.
Who this might be right for
Stage IB-IIIA Non-small Cell Lung Carcinoma
AstraZeneca 682